Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Debt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pulmonx (LUNG) FCF Margin (2019 - 2025)

Pulmonx (LUNG) has disclosed FCF Margin for 7 consecutive years, with 39.69% as the latest value for Q3 2025.

  • Quarterly FCF Margin fell 400.0% to 39.69% in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 36.7% through Sep 2025, up 648.0% year-over-year, with the annual reading at 39.32% for FY2024, 1662.0% up from the prior year.
  • FCF Margin for Q3 2025 was 39.69% at Pulmonx, down from 16.66% in the prior quarter.
  • The five-year high for FCF Margin was 16.66% in Q2 2025, with the low at 143.55% in Q1 2022.
  • Average FCF Margin over 5 years is 65.17%, with a median of 62.94% recorded in 2022.
  • The sharpest move saw FCF Margin surged 10297bps in 2021, then crashed -3630bps in 2022.
  • Over 5 years, FCF Margin stood at 97.24% in 2021, then surged by 35bps to 62.94% in 2022, then grew by 24bps to 47.72% in 2023, then soared by 30bps to 33.25% in 2024, then decreased by -19bps to 39.69% in 2025.
  • According to Business Quant data, FCF Margin over the past three periods came in at 39.69%, 16.66%, and 58.71% for Q3 2025, Q2 2025, and Q1 2025 respectively.